Yuko Omori

762 total citations
34 papers, 270 citations indexed

About

Yuko Omori is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Yuko Omori has authored 34 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Yuko Omori's work include Pancreatic and Hepatic Oncology Research (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Cancer Genomics and Diagnostics (10 papers). Yuko Omori is often cited by papers focused on Pancreatic and Hepatic Oncology Research (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Cancer Genomics and Diagnostics (10 papers). Yuko Omori collaborates with scholars based in Japan, United States and Italy. Yuko Omori's co-authors include Toru Furukawa, Michiaki Unno, Yusuke Ono, Yusuke Mizukami, Fuyuhiko Motoi, Masamichi Mizuma, Hidenori Karasaki, Tatsuo Hata, Takanori Morikawa and Kei Nakagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and Scientific Reports.

In The Last Decade

Yuko Omori

30 papers receiving 268 citations

Peers

Yuko Omori
Yuko Omori
Citations per year, relative to Yuko Omori Yuko Omori (= 1×) peers Hirohiko Kamiyama

Countries citing papers authored by Yuko Omori

Since Specialization
Citations

This map shows the geographic impact of Yuko Omori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Omori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Omori more than expected).

Fields of papers citing papers by Yuko Omori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Omori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Omori. The network helps show where Yuko Omori may publish in the future.

Co-authorship network of co-authors of Yuko Omori

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Omori. A scholar is included among the top collaborators of Yuko Omori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Omori. Yuko Omori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kimura, Masanobu, Yuriko Saiki, Tomohiko Ishikawa, et al.. (2025). Transcriptional regulation of ETV5 by mitogen-activated protein kinase via ETS-1 in human pancreatic cancer cells. Scientific Reports. 15(1). 12128–12128. 1 indexed citations
4.
Omori, Yuko, et al.. (2024). Clinicopathological Relevance of SMAD4 and RUNX3 in Patients With Resected Pancreatic Cancer. Pancreas. 54(4). e287–e294. 1 indexed citations
5.
Ono, Yusuke, Akihiro Hayashi, Kenji Takahashi, et al.. (2023). Multiplex Digital PCR Assay to Detect Multiple KRAS and GNAS Mutations Associated with Pancreatic Carcinogenesis from Minimal Specimen Amounts. Journal of Molecular Diagnostics. 25(6). 367–377. 6 indexed citations
6.
Ishikawa, Tomohiko, Takenori Ogawa, Masahiro Shiihara, et al.. (2023). Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials. iScience. 26(5). 106695–106695. 3 indexed citations
7.
Omori, Yuko, Masaharu Ishida, Hideo Ohtsuka, et al.. (2023). GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. Modern Pathology. 36(5). 100102–100102. 12 indexed citations
8.
Omori, Yuko, Fumiko Date, Yusuke Ono, et al.. (2023). Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms. Modern Pathology. 37(1). 100358–100358. 9 indexed citations
9.
Omori, Yuko, Toru Furukawa, Aldo Scarpa, & Claudio Luchini. (2023). Co-occurring IPMN and pancreatic cancer: the same or different? An overview from histology to molecular pathology. Journal of Clinical Pathology. 76(11). 734–739. 7 indexed citations
10.
Shiihara, Masahiro, Tomohiko Ishikawa, Yuriko Saiki, et al.. (2021). Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers. European Journal of Cancer. 148. 239–250. 16 indexed citations
11.
Kobayashi, Toshikazu, Yuko Omori, Yusuke Ono, et al.. (2021). Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas. Journal of Gastroenterology. 56(6). 581–592. 21 indexed citations
12.
Ikeda, Mio, Shin Miura, Shin Hamada, et al.. (2021). Acinar Cell Carcinoma with Morphological Change in One Month. Internal Medicine. 60(17). 2799–2806. 3 indexed citations
13.
Nagano, Masaaki, Shinji Kohsaka, Takuo Hayashi, et al.. (2021). Comprehensive molecular profiling of pulmonary pleomorphic carcinoma. npj Precision Oncology. 5(1). 57–57. 13 indexed citations
14.
Hata, Tatsuo, Masamichi Mizuma, Fuyuhiko Motoi, et al.. (2020). GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype. Scientific Reports. 10(1). 17761–17761. 26 indexed citations
15.
Ōtsuka, Hideo, Tatsuo Hata, Kunihiro Masuda, et al.. (2020). A case of juvenile hilar cholangiocarcinoma associated with non-dilated pancreaticobiliary maljunction. 34(4). 772–780.
16.
Omori, Yuko, Yusuke Ono, Toshikazu Kobayashi, et al.. (2020). How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(1). 21–31. 18 indexed citations
17.
Mizuma, Masamichi, Tatsuo Hata, Takeshi Aoki, et al.. (2020). Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes. The Journal of Pathology. 251(1). 38–48. 37 indexed citations
18.
Amano, Yasuo, et al.. (2019). Glomerulocystic kidney identified in older patients by magnetic resonance imaging. Medicine. 98(17). e15350–e15350.
19.
Nagai, Kazumasa, Yusuke Mizukami, Yuko Omori, et al.. (2019). Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection. Modern Pathology. 33(5). 971–980. 18 indexed citations
20.
T, Oka, et al.. (1987). The fate of living related donor kidney recipients after conversion from cyclosporine to azathioprine.. PubMed. 19(1 Pt 3). 2012–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026